Research consistently shows that people are treated differently based on body size
The strongest prevention framework is risk reduction across multiple systems: blood pressure control, lipid and cardiometabolic risk management, physical activity, resistance training, sleep quality, hearing and vision support, glucose regulation, alcohol moderation, social connection, and treatment of relevant medical conditions
Long-acting GLP-1 receptor (GLP-1R) mono-agonists have been developed to engage in beta cell glucose-dependent insulinotropic effect, while also acting within key feeding regions of the central nervous system to influence satiety
Journal of Clinical Endocrinology & Metabolism , 109(4), 12341246
Image: United States - As brand-name GLP-1 medications like Wegovy and Ozempic continue to carry monthly costs exceeding $1,000 without insurance, MedVi today released a comprehensive overview of cheaper, compounded alternatives available to American patients
Barriers between the brain and the peripheral circulation system There are three barriers between the brain and the peripheral circulation system, known as the blood brain barrier (BBB), the blood-cerebrospinal fluid (CSF) barrier defined here as BCB, and the brain circumventricular organs (CVOs) (Figure 1)